[randomized clinical trials of antifibrotic drug in idiopathic pulmonary fibrosis: an update].
作者信息
Li Y H, Ye Q
出版信息
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):256-262. doi: 10.3760/cma.j.issn.1001-0939.2020.03.025.
Abstract
摘要
相似文献
1
[randomized clinical trials of antifibrotic drug in idiopathic pulmonary fibrosis: an update].
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):256-262. doi: 10.3760/cma.j.issn.1001-0939.2020.03.025.
2
Treatments for idiopathic pulmonary fibrosis.特发性肺纤维化的治疗方法。
N Engl J Med. 2014 Aug 21;371(8):783-4. doi: 10.1056/NEJMc1407776.
3
Treatments for idiopathic pulmonary fibrosis.特发性肺纤维化的治疗方法。
N Engl J Med. 2014 Aug 21;371(8):782. doi: 10.1056/NEJMc1407776.
4
Treatments for idiopathic pulmonary fibrosis.特发性肺纤维化的治疗方法。
N Engl J Med. 2014 Aug 21;371(8):782. doi: 10.1056/NEJMc1407776.
5
Pirfenidone reduced disease progression in idiopathic pulmonary fibrosis.吡非尼酮可延缓特发性肺纤维化的疾病进展。
Ann Intern Med. 2014 Oct 21;161(8):JC4-5. doi: 10.7326/0003-4819-161-8-201410210-02004.
6
Treatments for idiopathic pulmonary fibrosis.特发性肺纤维化的治疗方法。
N Engl J Med. 2014 Aug 21;371(8):781. doi: 10.1056/NEJMc1407776.
7
A new hope for idiopathic pulmonary fibrosis.特发性肺纤维化的新希望。
N Engl J Med. 2014 May 29;370(22):2142-3. doi: 10.1056/NEJMe1403448. Epub 2014 May 18.
8
Pirfenidone for idiopathic pulmonary fibrosis, thrombocytosis in chronic obstructive pulmonary disease exacerbations, and a longitudinal study on e-cigarettes.吡非尼酮用于特发性肺纤维化、慢性阻塞性肺疾病急性加重期的血小板增多症以及一项关于电子烟的纵向研究。
Am J Respir Crit Care Med. 2014 Sep 15;190(6):699-700. doi: 10.1164/rccm.201406-1188RR.
9
[New treatment options for idiopathic pulmonary fibrosis?].[特发性肺纤维化的新治疗选择？]
Pneumologie. 2009 Sep;63(9):512-8. doi: 10.1055/s-0029-1214953. Epub 2009 Aug 25.
10
Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.特发性肺纤维化患者对吡非尼酮治疗的个体内反应。
Am J Respir Crit Care Med. 2015 Jan 1;191(1):110-3. doi: 10.1164/rccm.201406-1106LE.
Zotero 插件